203 related articles for article (PubMed ID: 16803511)
61. Methylation profile of genes CDKN2A (p14 and p16), DAPK1, CDH1, and ADAM23 in head and neck cancer.
Calmon MF; Colombo J; Carvalho F; Souza FP; Filho JF; Fukuyama EE; Camargo AA; Caballero OL; Tajara EH; Cordeiro JA; Rahal P
Cancer Genet Cytogenet; 2007 Feb; 173(1):31-7. PubMed ID: 17284367
[TBL] [Abstract][Full Text] [Related]
62. Influence of HRH2 promoter polymorphism on aberrant DNA methylation of DAPK and CDH1 in the gastric epithelium.
Nomura T; Tahara T; Shiroeda H; Minato T; Matsue Y; Hayashi R; Matsunaga K; Otsuka T; Nakamura M; Toshikuni N; Shibata T; Arisawa T
BMC Gastroenterol; 2013 Jan; 13():1. PubMed ID: 23280118
[TBL] [Abstract][Full Text] [Related]
63. Methylation analysis for multiple gene promoters in non-small cell lung cancers in high indoor air pollution region in China.
Huang X; Wu C; Fu Y; Guo L; Kong X; Cai H
Bull Cancer; 2018 Sep; 105(9):746-754. PubMed ID: 30126609
[TBL] [Abstract][Full Text] [Related]
64. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
[TBL] [Abstract][Full Text] [Related]
65. [Hypermethylation of the death-associated protein kinase promoter in laryngeal squamous cell cancer].
Zhang S; Kong WJ
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):469-71. PubMed ID: 15555335
[TBL] [Abstract][Full Text] [Related]
66. Promoter hypermethylation profile of kidney cancer with new proapoptotic p53 target genes and clinical implications.
Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Köllermann J; Miller K; Schrader M
Clin Cancer Res; 2006 Sep; 12(17):5040-6. PubMed ID: 16951219
[TBL] [Abstract][Full Text] [Related]
67. [Methylation and expression of gene p16INK4a and RB in breast carcinoma].
Zhao YF; Shen SP; Jiang JY; Geng H; Guo JG; Xie LP
Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):377-81. PubMed ID: 21055153
[TBL] [Abstract][Full Text] [Related]
68. Epstein-Barr virus and p16INK4A methylation in squamous cell carcinoma and precancerous lesions of the cervix uteri.
Kim NR; Lin Z; Kim KR; Cho HY; Kim I
J Korean Med Sci; 2005 Aug; 20(4):636-42. PubMed ID: 16100457
[TBL] [Abstract][Full Text] [Related]
69. OPCML gene promoter methylation and gene expression in tumor and stroma cells of invasive cervical carcinoma.
Ye F; Zhang SF; Xie X; Lu WG
Cancer Invest; 2008 Jul; 26(6):569-74. PubMed ID: 18584347
[TBL] [Abstract][Full Text] [Related]
70. Alteration of p16 and p15 genes in human uterine tumours.
Nakashima R; Fujita M; Enomoto T; Haba T; Yoshino K; Wada H; Kurachi H; Sasaki M; Wakasa K; Inoue M; Buzard G; Murata Y
Br J Cancer; 1999 May; 80(3-4):458-67. PubMed ID: 10408854
[TBL] [Abstract][Full Text] [Related]
71. Promoter hypermethylation of p16INK4a, E-cadherin, O6-MGMT, DAPK and FHIT in adenocarcinomas of the esophagus, esophagogastric junction and proximal stomach.
Schildhaus HU; Kröckel I; Lippert H; Malfertheiner P; Roessner A; Schneider-Stock R
Int J Oncol; 2005 Jun; 26(6):1493-500. PubMed ID: 15870861
[TBL] [Abstract][Full Text] [Related]
72. Methylated TMS1 and DAPK genes predict prognosis and response to chemotherapy in gastric cancer.
Kato K; Iida S; Uetake H; Takagi Y; Yamashita T; Inokuchi M; Yamada H; Kojima K; Sugihara K
Int J Cancer; 2008 Feb; 122(3):603-8. PubMed ID: 17943730
[TBL] [Abstract][Full Text] [Related]
73. DAPK promotor methylation is an early event in colorectal carcinogenesis.
Mittag F; Kuester D; Vieth M; Peters B; Stolte B; Roessner A; Schneider-Stock R
Cancer Lett; 2006 Aug; 240(1):69-75. PubMed ID: 16246486
[TBL] [Abstract][Full Text] [Related]
74. PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population.
Sushma PS; Jamil K; Kumar PU; Satyanarayana U; Ramakrishna M; Triveni B
Tumour Biol; 2016 Jun; 37(6):7625-32. PubMed ID: 26687648
[TBL] [Abstract][Full Text] [Related]
75. Methylation profiling of archived non-small cell lung cancer: a promising prognostic system.
Safar AM; Spencer H; Su X; Coffey M; Cooney CA; Ratnasinghe LD; Hutchins LF; Fan CY
Clin Cancer Res; 2005 Jun; 11(12):4400-5. PubMed ID: 15958624
[TBL] [Abstract][Full Text] [Related]
76. Death-associated protein kinase (DAPK) promoter methylation and response to neoadjuvant radiochemotherapy in esophageal cancer.
Brabender J; Arbab D; Huan X; Vallböhmer D; Grimminger P; Ling F; Neiss S; Bollschweiler E; Schneider PM; Hölscher AH; Metzger R
Ann Surg Oncol; 2009 May; 16(5):1378-83. PubMed ID: 19224282
[TBL] [Abstract][Full Text] [Related]
77. Promoter hypermethylation of death-associated protein kinase gene in cholangiocarcinoma.
Liu XF; Kong FM; Xu Z; Yu SP; Sun FB; Zhang CS; Huang QX; Zhou XT; Song ZW
Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):407-11. PubMed ID: 17690039
[TBL] [Abstract][Full Text] [Related]
78. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.
Chang MS; Uozaki H; Chong JM; Ushiku T; Sakuma K; Ishikawa S; Hino R; Barua RR; Iwasaki Y; Arai K; Fujii H; Nagai H; Fukayama M
Clin Cancer Res; 2006 May; 12(10):2995-3002. PubMed ID: 16707594
[TBL] [Abstract][Full Text] [Related]
79. Association between Gene Promoter Methylation and Cervical Cancer Development: Global Distribution and A Meta-analysis.
El Aliani A; El-Abid H; El Mallali Y; Attaleb M; Ennaji MM; El Mzibri M
Cancer Epidemiol Biomarkers Prev; 2021 Mar; 30(3):450-459. PubMed ID: 33441308
[TBL] [Abstract][Full Text] [Related]
80. Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data.
Yang HJ; Liu VW; Wang Y; Tsang PC; Ngan HY
BMC Cancer; 2006 Aug; 6():212. PubMed ID: 16928264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]